Mission: At fred hutchinson cancer research center, home to three nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, hiv/aids and other life-threatening diseases.
Programs: Vaccine and infectious disease division (vidd): vidd integrates the latest in computational, laboratory and clinical research methods to advance the understanding of microbial pathogenesis and infectious disease processes. Vidd researchers partner with scientists at laboratory, clinical and field sites in africa, asia and europe. The division has specific initiatives in uganda, china and the republic of south africa to advance the understanding of infection-related cancers and infectious diseases that affect high-risk populations in these regions. Vidd scientists around the world including clinicians, clinical trials specialists, statisticians, computational biologists and basic scientists take pride in their collaborative efforts to predict, detect, treat and prevent infectious diseases in humans.
clinical research division: the clinical research division conducts laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our clinical researchers are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.
public health sciences division: the public health sciences division identifies strategies that would ultimately reduce the incidence of and mortality from cancer and other diseases. Using large populations as their "laboratory," our public-health researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors. Identifying such cancer causes can lead to better cancer-detection methods and new ways to help people adopt healthier lifestyles to minimize or avoid their risk of getting the disease in the first place. Our statistical, epidemiological and prevention projects include studies around the world.